Back
Innate Pharma SA Stock Price Chart
Sell
39
IPHA
Innate Pharma SA
Last Price:
2.92
Seasonality Move:
-6.03%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IPHA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Innate Pharma SA Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.59 | Buy |
20-day SMA: | 2.5 | Buy |
50-day SMA: | 2.5 | Buy |
200-day SMA: | 2.61 | Buy |
8-day EMA: | 2.59 | Buy |
20-day EMA: | 2.54 | Buy |
50-day EMA: | 2.53 | Buy |
200-day EMA: | 2.63 | Buy |
Innate Pharma SA Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.04 | Buy |
Relative Strength Index (14 RSI): | 57.79 | Buy |
Chaikin Money Flow: | 12420 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.39 - 2.59) | Buy |
Bollinger Bands (100): | (2.44 - 2.72) | Buy |
Innate Pharma SA Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Innate Pharma SA Stock
Is Innate Pharma SA Stock a Buy?
- Innate Pharma SA share price is 2.71 while IPHA 8-day simple moving average is 2.59, which is a Buy signal.
- The stock price of IPHA is 2.71 while Innate Pharma SA 20-day SMA is 2.50, which makes it a Buy.
- Innate Pharma SA 50-day simple moving average is 2.50 while IPHA share price is 2.71, making it a Buy technically.
- IPHA stock price is 2.71 and Innate Pharma SA 200-day simple moving average is 2.61, creating a Buy signal.
IPHA Technical Analysis vs Fundamental Analysis
Sell
39
Innate Pharma SA (IPHA)
is a Sell
Is Innate Pharma SA a Buy or a Sell?
-
Innate Pharma SA stock is rated a Sell
The current Innate Pharma SA [IPHA] share price is $2.71. The Score for IPHA is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Innate Pharma SA Stock Info
Market Cap:
219.07M
Price in USD:
2.71
Share Volume:
12.42K
Innate Pharma SA 52-Week Range
52-Week High:
3.57
52-Week Low:
1.81
Sell
39
Innate Pharma SA (IPHA)
is a Sell
Innate Pharma SA Share Price Forecast
-
What is the Innate Pharma SA stock price today?
The Innate Pharma SA stock price is 2.71 USD today. -
Will IPHA stock go up or go down?
Innate Pharma SA> share price is forecast to RISE/FALL based on technical indicators -
Is Innate Pharma SA overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Innate Pharma SA is overvalued.
Is Innate Pharma SA Stock a Buy?
- Innate Pharma SA share price is 2.71 while IPHA 8-day exponential moving average is 2.59, which is a Buy signal.
- The stock price of IPHA is 2.71 while Innate Pharma SA 20-day EMA is 2.54, which makes it a Buy.
- Innate Pharma SA 50-day exponential moving average is 2.53 while IPHA share price is 2.71, making it a Buy technically.
- IPHA stock price is 2.71 and Innate Pharma SA 200-day simple moving average is 2.63, creating a Buy signal.
Fundamental Analysis of Innate Pharma SA
Is Innate Pharma SA a good investment?
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.52 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Innate Pharma SA
Should I short Innate Pharma SA stock?
- IPHA Moving Average Covergence Divergence (MACD) indicator is 0.04, suggesting Innate Pharma SA is a Buy
- Innate Pharma SA Relative Strength Index (RSI) is 57.79, which suggest Innate Pharma SA is overbought
- The Bollinger Bands (25) for Innate Pharma SA is (2.39 - 2.59), which suggest Innate Pharma SA is a Buy
- The Bollinger Bands (100) for Innate Pharma SA is (2.44 - 2.72), which suggest Innate Pharma SA is a Buy
* Innate Pharma SA stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.